These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34944475)

  • 1. Butyrate and Metformin Affect Energy Metabolism Independently of the Metabolic Phenotype in the Tumor Therapy Model.
    Meyer FB; Marx C; Spangel SB; Thierbach R
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin alters therapeutic effects in the BALB/c tumor therapy model.
    Meyer FB; Goebel S; Spangel SB; Leovsky C; Hoelzer D; Thierbach R
    BMC Cancer; 2021 May; 21(1):629. PubMed ID: 34044797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin delays AKT/c-Met-driven hepatocarcinogenesis by regulating signaling pathways for de novo lipogenesis and ATP generation.
    Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Zheng G; Qiu Z
    Toxicol Appl Pharmacol; 2019 Feb; 365():51-60. PubMed ID: 30625338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin treatment response is dependent on glucose growth conditions and metabolic phenotype in colorectal cancer cells.
    Alhourani AH; Tidwell TR; Bokil AA; Røsland GV; Tronstad KJ; Søreide K; Hagland HR
    Sci Rep; 2021 May; 11(1):10487. PubMed ID: 34006970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy.
    Phoenix KN; Vumbaca F; Fox MM; Evans R; Claffey KP
    Breast Cancer Res Treat; 2010 Sep; 123(2):333-44. PubMed ID: 20204498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Butyrate can act as a stimulator of growth or inducer of apoptosis in human colonic epithelial cell lines depending on the presence of alternative energy sources.
    Singh B; Halestrap AP; Paraskeva C
    Carcinogenesis; 1997 Jun; 18(6):1265-70. PubMed ID: 9214612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced anti-tumor activity and cytotoxic effect on cancer stem cell population of metformin-butyrate compared with metformin HCl in breast cancer.
    Lee KM; Lee M; Lee J; Kim SW; Moon HG; Noh DY; Han W
    Oncotarget; 2016 Jun; 7(25):38500-38512. PubMed ID: 27223262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low glucose enhanced metformin's inhibitory effect on pancreatic cancer cells by suppressing glycolysis and inducing energy stress via up-regulation of miR-210-5p.
    Ma M; Ma C; Li P; Ma C; Ping F; Li W; Xu L; Zhang H; Sun Q; Li Y
    Cell Cycle; 2020 Sep; 19(17):2168-2181. PubMed ID: 32718270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Butyrate elicits a metabolic switch in human colon cancer cells by targeting the pyruvate dehydrogenase complex.
    Blouin JM; Penot G; Collinet M; Nacfer M; Forest C; Laurent-Puig P; Coumoul X; Barouki R; Benelli C; Bortoli S
    Int J Cancer; 2011 Jun; 128(11):2591-601. PubMed ID: 20715114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of metformin treatment in vivo on acute and long-term energy metabolism and progesterone production in vitro by granulosa cells from women with polycystic ovary syndrome.
    Maruthini D; Harris SE; Barth JH; Balen AH; Campbell BK; Picton HM
    Hum Reprod; 2014 Oct; 29(10):2302-16. PubMed ID: 25139174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rewired Cellular Metabolic Profiles in Response to Metformin under Different Oxygen and Nutrient Conditions.
    Liu S; Washio J; Sato S; Abiko Y; Shinohara Y; Kobayashi Y; Otani H; Sasaki S; Wang X; Takahashi N
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin and the ATM DNA damage response (DDR): accelerating the onset of stress-induced senescence to boost protection against cancer.
    Menendez JA; Cufí S; Oliveras-Ferraros C; Martin-Castillo B; Joven J; Vellon L; Vazquez-Martin A
    Aging (Albany NY); 2011 Nov; 3(11):1063-77. PubMed ID: 22170748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic switching in the hypoglycemic and antitumor effects of metformin on high glucose induced HepG2 cells.
    Lv Y; Tian N; Wang J; Yang M; Kong L
    J Pharm Biomed Anal; 2018 Jul; 156():153-162. PubMed ID: 29705631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose promotes breast cancer aggression and reduces metformin efficacy.
    Wahdan-Alaswad R; Fan Z; Edgerton SM; Liu B; Deng XS; Arnadottir SS; Richer JK; Anderson SM; Thor AD
    Cell Cycle; 2013 Dec; 12(24):3759-69. PubMed ID: 24107633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin attenuates hepatoma cell proliferation by decreasing glycolytic flux through the HIF-1α/PFKFB3/PFK1 pathway.
    Hu L; Zeng Z; Xia Q; Liu Z; Feng X; Chen J; Huang M; Chen L; Fang Z; Liu Q; Zeng H; Zhou X; Liu J
    Life Sci; 2019 Dec; 239():116966. PubMed ID: 31626790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Butyrate Suppresses the Proliferation of Colorectal Cancer Cells via Targeting Pyruvate Kinase M2 and Metabolic Reprogramming.
    Li Q; Cao L; Tian Y; Zhang P; Ding C; Lu W; Jia C; Shao C; Liu W; Wang D; Ye H; Hao H
    Mol Cell Proteomics; 2018 Aug; 17(8):1531-1545. PubMed ID: 29739823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent targets of glycolysis and oxidative phosphorylation result in additive effects of metformin and starvation in colon and breast cancer.
    Marini C; Bianchi G; Buschiazzo A; Ravera S; Martella R; Bottoni G; Petretto A; Emionite L; Monteverde E; Capitanio S; Inglese E; Fabbi M; Bongioanni F; Garaboldi L; Bruzzi P; Orengo AM; Raffaghello L; Sambuceti G
    Sci Rep; 2016 Jan; 6():19569. PubMed ID: 26794854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin is synthetically lethal with glucose withdrawal in cancer cells.
    Menendez JA; Oliveras-Ferraros C; Cufí S; Corominas-Faja B; Joven J; Martin-Castillo B; Vazquez-Martin A
    Cell Cycle; 2012 Aug; 11(15):2782-92. PubMed ID: 22809961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth.
    Hirsch HA; Iliopoulos D; Struhl K
    Proc Natl Acad Sci U S A; 2013 Jan; 110(3):972-7. PubMed ID: 23277563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin suppressed the proliferation of LoVo cells and induced a time-dependent metabolic and transcriptional alteration.
    He J; Wang K; Zheng N; Qiu Y; Xie G; Su M; Jia W; Li H
    Sci Rep; 2015 Nov; 5():17423. PubMed ID: 26616174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.